These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5795800)

  • 1. A retrospective study of the pharmacokinetics of heparin.
    Estes JW; Pelikan EW; Krüger-Thiemer E
    Clin Pharmacol Ther; 1969; 10(3):329-37. PubMed ID: 5795800
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism and anticoagulant effect of 51Cr-labelled heparin.
    Alánt O; Varga L; Antoni F; Karácsonyi S; Faller J
    Acta Physiol Acad Sci Hung; 1973; 43(3):261-7. PubMed ID: 4790805
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin action on bleeding time and its rate of removal from blood in dogs and rabbits.
    Magalhães JR
    Acta Physiol Lat Am; 1969; 19(3):243-8. PubMed ID: 5374277
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of protamine on heparin antithrombin III complexes. In vivo studies.
    Kitani T; Nagarajan SC; Shanberge JN
    Thromb Res; 1980 Feb 1-15; 17(3-4):375-82. PubMed ID: 7368169
    [No Abstract]   [Full Text] [Related]  

  • 5. The fate of heparin in the body.
    Estes JW
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 Pt1):45-57. PubMed ID: 808390
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemorheological studies of the effect of heparin on the course of coagulation.
    Overholser KA; Baysinger CB; Harris TR; Deveau T
    Thromb Haemost; 1976 Apr; 35(2):447-59. PubMed ID: 989642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous 35S-labeled heparin: organ distribution and metabolism.
    Stau T; Metz J; Taugner R
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 280(1):93-102. PubMed ID: 4273672
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of levomycetin on blood coagulation and the sensitivity of animals to heparin].
    Zolotukhin SI; Ovchinnikova LK
    Farmakol Toksikol; 1970; 33(6):703-7. PubMed ID: 5518492
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutralization of heparin by cellular blood elements.
    Zuckerman L; Ramstack JM; Vagher JP; Caprini JA; Mockros LF
    Thromb Res; 1975 Jul; 7(1):149-59. PubMed ID: 1154333
    [No Abstract]   [Full Text] [Related]  

  • 10. Appearance of heparin antithrombin-active chains in vivo after injection of commercial heparin and in anaphylaxis.
    Levy SW; Jaques LB
    Thromb Res; 1978 Sep; 13(3):429-41. PubMed ID: 741437
    [No Abstract]   [Full Text] [Related]  

  • 11. A primate model (Macaca mulatta) to study the pharmacokinetics of heparin and its fractions.
    Fareed J; Kumar A; Rock A; Walenga JM; Davis P
    Semin Thromb Hemost; 1985 Apr; 11(2):138-54. PubMed ID: 4035364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current data on heparin].
    Choay J
    Agressologie; 1983 Nov; 24(10):491-4. PubMed ID: 6367508
    [No Abstract]   [Full Text] [Related]  

  • 13. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research.
    Wilkerson RD; Conran PB; Greene SL
    Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model for R.E.S. blood clearance involving Michaelis-Menten kinetics.
    Hofer C; Bezkorovainy A; Saba TM
    Physiol Chem Phys; 1973; 5(6):515-24. PubMed ID: 4786103
    [No Abstract]   [Full Text] [Related]  

  • 15. The kinetics of heparin.
    Estes JW
    Ann N Y Acad Sci; 1971 Jul; 179():187-204. PubMed ID: 5285374
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interaction of heparin-containing polymers with plasma and blood].
    Platé NA; Valuev LI; Gumirova FKh; Zimin NK; Rozenfel'd MA
    Vopr Med Khim; 1982; 28(3):97-101. PubMed ID: 7101821
    [No Abstract]   [Full Text] [Related]  

  • 17. Some aspects of the pharmacology of oral anticoagulants.
    Coon WW; Willis PW
    Clin Pharmacol Ther; 1970; 11(3):312-36. PubMed ID: 4192279
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on heparin metabolism in hemostatically different dogs.
    Oliveira MM
    Thromb Diath Haemorrh; 1966 Dec; 16(3):636-44. PubMed ID: 5996679
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the coagulation and fibrinolytic system in hepatectomized dogs].
    Alánt O; Karácsonyi S; Faller J; Szécsény A
    Acta Chir Acad Sci Hung; 1973; 14(4):321-34. PubMed ID: 4595475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.